Eye neoplasm (ocular oncology): causes, types, diagnosis, and treatment

Types and origins

Eye tumors can be classified as primary (originating within the eye or adnexa) or secondary (spread from another body site). Secondary disease is commonly described as metastatic cancer. The most frequent cancers that spread to the eye arise from the breast (breast) and the lung (lung), but metastases may also come from the prostate (prostate), kidney (kidney), thyroid (thyroid), skin (cutaneous melanoma, skin) and from gastrointestinal or hematologic malignancies such as colon cancers or leukemias (blood or bone marrow).

Common primary intraocular tumors include uveal melanoma (in adults) and retinoblastoma (in children). Surface and periocular tumors include conjunctival squamous cell carcinoma, sebaceous carcinoma of the eyelid and others; behavior and treatment vary with type and stage.

Clinical features and diagnosis

Symptoms depend on tumor location and size and may include vision loss, flashes, floaters, a visible mass on the eyelid, or redness and pain. Diagnosis combines clinical examination with imaging and laboratory methods. Typical tools include:

• Slit-lamp and dilated fundus examination
• Ocular ultrasound and optical coherence tomography (OCT)
• Fluorescein angiography and cross-sectional imaging (MRI or CT)
• Biopsy or cytology when tissue diagnosis is required

Treatment and prognosis

Management is tailored to tumor type, size, location, patient age and overall health. Options include local excision, plaque brachytherapy or external beam radiotherapy, systemic chemotherapy or targeted therapy, cryotherapy, and in severe cases enucleation (removal of the eye). For some pediatric tumors such as retinoblastoma, early detection and modern multidisciplinary care can result in high cure rates while preserving life and often vision.

Importance, distinctions and follow-up

Distinguishing primary ocular tumors from metastatic lesions is crucial because treatment and prognosis differ. Eye neoplasms often require coordination between ophthalmologists, oncologists, radiologists and pathologists. Long-term follow-up is important for detecting recurrence, managing treatment side effects and monitoring for systemic disease when metastasis is possible.

Patients with unexplained ocular masses or rapid changes in vision should be referred promptly to specialists in ocular oncology or ocular tumor services for evaluation and appropriate imaging. Multidisciplinary care improves diagnostic accuracy and outcomes.